Escalon Medical Corp.
https://www.escalonmedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Escalon Medical Corp.
Executive Decisions Roundup
Another Coca-Cola exec pops up at NBTY; Hussain helms Glaxo pharma globally; China TCM office veteran returns; T-Bird tabs Huang as COO; and Lee named Calif. DTSC director.
Executive Decisions Roundup
Another Coca-Cola exec pops up at NBTY; Hussain helms Glaxo pharma globally; China TCM office veteran returns; T-Bird tabs Huang as COO; and Lee named Calif. DTSC director.
Execs On The Move, November 2013
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Deals In Depth: October 2012
In a deal valued at $272 million, AZ got exclusive global rights to Ardelyx’s NHE3 program. Pfizer exercised an option to buy spec pharma NextWave for $255 million up front. Biophama companies raised almost $2 billion in October propelled by public offerings. Early venture rounds dominated device financing, which totaled $193 million.
Company Information
- Industry
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Ultrasound
-
Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
-
- Biocode Hycel
- Escalon Digital Solutions, Inc.
- Escalon Holdings, Inc.
- Escalon IP Holdings, Inc.
- Sonomed, Inc.
- Sonomed IP Holdings, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice